Study: Past Long-term DMT Use Tapers Risk of Current MS Progression

Study: Past Long-term DMT Use Tapers Risk of Current MS Progression

282358

Study: Past Long-term DMT Use Tapers Risk of Current MS Progression

Long-term use of disease-modifying therapies (DMTs) in people with relapsing-remitting multiple sclerosis (RRMS) has a beneficial cumulative effect compared to shorter treatments, delaying the development of irreversible disability and conversion to secondary progressive MS (SPMS), a recent study shows.  The study, “Cumulative effects of therapies on disability in relapsing multiple sclerosis,” was published in the Multiple Sclerosis Journal. The short-term efficacy of DMTs in MS has been demonstrated in clinical trials; yet their long-term impact…

You must be logged in to read/download the full post.